These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 19940965)

  • 1. Legal basis of the Advanced Therapies Regulation.
    Jekerle V; Schröder C; Pedone E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):4-8. PubMed ID: 19940965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAT--the new committee for advanced therapies at the European Medicines Agency.
    Celis P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):9-13. PubMed ID: 20084354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory requirements for clinical trial and marketing authorisation application for cell-based medicinal products.
    Salmikangas P; Flory E; Reinhardt J; Hinz T; Maciulaitis R
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):24-9. PubMed ID: 19940964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical trials with advanced therapy medicinal products].
    Schüssler-Lenz M; Schneider CK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):68-74. PubMed ID: 20011994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regulation (EC) No. 1394/2007 on advanced therapy medicinal products : Incorporation into national law].
    Dwenger A; Strassburger J; Schwerdtfeger W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):14-9. PubMed ID: 20033662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Small- and Medium-sized Enterprises Office (SME Office) at the European Medicines Agency.
    Carr M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):20-3. PubMed ID: 20101799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The European hospital exemption clause-new option for gene therapy?
    Buchholz CJ; Sanzenbacher R; Schüle S
    Hum Gene Ther; 2012 Jan; 23(1):7-12. PubMed ID: 22247961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marketing Regulatory Oversight of Advanced Therapy Medicinal Products (ATMPs) in Europe: The EMA/CAT Perspective.
    Salmikangas P; Schuessler-Lenz M; Ruiz S; Celis P; Reischl I; Menezes-Ferreira M; Flory E; Renner M; Ferry N
    Adv Exp Med Biol; 2015; 871():103-30. PubMed ID: 26374215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental risk assessment for medicinal products containing genetically modified organisms.
    Anliker B; Longhurst S; Buchholz CJ
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):52-7. PubMed ID: 19940966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Access to advanced therapy medicinal products in the EU: where do we stand?
    Mahalatchimy A
    Eur J Health Law; 2011 May; 18(3):305-17. PubMed ID: 21870592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European approval system for advanced therapies: good news for patients and innovators alike.
    Hughes-Wilson W; Mackay D
    Regen Med; 2007 Jan; 2(1):5-6. PubMed ID: 17465768
    [No Abstract]   [Full Text] [Related]  

  • 12. [The certification of advanced therapy medicinal products. A quality label for product development in small and medium-sized enterprises].
    Berger A; Schüle S; Flory E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):816-21. PubMed ID: 21698534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [European Marketing Authorisation: a long process. Experiences of small biotech companies with the ATMP regulation].
    Buljovčić Z
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):831-8. PubMed ID: 21698536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Creating conditions for the success of the French industrial advanced therapy sector.
    Lirsac PN; Blin O; Magalon J; ; Angot P; de Barbeyrac E; Bilbault P; Bourg E; Damour O; Faure P; Ferry N; Garbil B; Larghero J; Nguon M; Pattou F; Thumelin S; Yates F
    Therapie; 2015; 70(1):69-94. PubMed ID: 25747840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulatory requirements for clinical trial and marketing authorisation application for gene therapy medicinal products.
    Schüle S; Renner M; Longhurst S; Narayanan G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):30-7. PubMed ID: 20012927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Requirements for long-term follow-up on efficacy and safety of advanced therapy medicinal products. Risk management and traceability].
    Klug B; Reinhardt J; Schröder C
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):58-62. PubMed ID: 19949763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The advanced therapy classification procedure. Overview of experience gained so far.
    Voltz-Girolt C; Celis P; Boucaumont M; D'Apote L; Pinheiro MH; Papaluca-Amati M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2011 Jul; 54(7):811-5. PubMed ID: 21698533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Important aspects of virus safety of advanced therapy medicinal products].
    Blümel J; Stühler A
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):38-44. PubMed ID: 19937308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems in microbial safety of advanced therapy medicinal products. Squaring the circle].
    Montag-Lessing T; Störmer M; Schurig U; Brachert J; Bubenzer M; Sicker U; Beshir R; Spreitzer I; Löschner B; Bache C; Becker B; Schneider CK
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Jan; 53(1):45-51. PubMed ID: 20012926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GMP facilities for manufacturing of advanced therapy medicinal products for clinical trials: an overview for clinical researchers.
    Alici E; Blomberg P
    Curr Gene Ther; 2010 Dec; 10(6):508-15. PubMed ID: 21054243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.